As of Aug 04
| -0.42 / -1.98%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 26.00, with a high estimate of 34.00 and a low estimate of 20.00. The median estimate represents a +25.30% increase from the last price of 20.75.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.